Lausanne, Switzerland

Elhadji Dioum

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elhadji Dioum. Retrieved from https://idiyas.com/inventor/elhadji-dioum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elhadji Dioum: Innovator in Diabetes Treatment

Introduction

Elhadji Dioum is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of diabetes treatment through his innovative research and development of new compounds.

Latest Patents

Elhadji Dioum holds 1 patent for his invention titled "Isoxazole treatments for diabetes." This patent relates to compounds and methods designed to induce the synthesis and secretion of insulin from pancreatic beta cells. The methods described in his patent can be applied in vitro, ex vivo, or in vivo, making them versatile for various applications in diabetes treatment.

Career Highlights

Elhadji Dioum is affiliated with the University of Texas System, where he continues to advance his research in diabetes and related fields. His work has the potential to significantly impact the lives of individuals suffering from diabetes by providing new therapeutic options.

Collaborations

Throughout his career, Elhadji Dioum has collaborated with esteemed colleagues such as Jay Schneider and Doug E Frantz. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Elhadji Dioum's contributions to diabetes treatment through his patented inventions highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also offers hope for improved treatment options for diabetes patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…